Overview

Adrenocorticotropic Hormone (ACTH) Treatment of Nephrotic Range Proteinuria in Diabetic Nephropathy (NRDN)

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
This is a prospective open labeled trial examining the efficacy of ACTHar Gel (porcine ACTH) on the level of proteinuria in patients with diabetic nephropathy and nephrotic range proteinuria.
Phase:
Phase 4
Details
Lead Sponsor:
Southeast Renal Research Institute
Collaborator:
Mallinckrodt
Treatments:
Adrenocorticotropic Hormone
beta-Endorphin
Melanocyte-Stimulating Hormones